The latest edition of the mhGAP guideline has been developed to address the growing challenges of mental, neurological and substance use conditions (MNS) in low- and middle-income countries. With 30 updated and 18 new recommendations, along with 90 existing ones, this guidance is designed to improve the ability of non-specialist health professionals to provide effective treatment and care for people with MNS.
The need for improved capacity to address MSM is a growing concern, and the mhGAP guidelines aim to meet this challenge by providing high-quality, timely, transparent and evidence-based guidance. This third iteration of the guidance reflects years of investment in the mhGAP program over the past 15 years. The revised recommendations aim to ensure that mhGAP continues to be a valuable resource for non-specialist health professionals in these countries.